Newly Identified Diabetes Up With Medicaid Expansion

This article originally appeared here.
Share this content:
Newly Identified Diabetes Up With Medicaid Expansion
Newly Identified Diabetes Up With Medicaid Expansion

WEDNESDAY, March 25, 2015 (HealthDay News) -- Medicaid expansion is associated with an increase in diabetes diagnosis, according to a study published online March 23 in Diabetes Care.

Harvey W. Kaufman, M.D., M.B.A., from Quest Diagnostics in Madison, N.J., and colleagues examined the impact of Medicaid expansion on the number of patients with newly identified diabetes among new enrollees in Medicaid (aged 19 to 64 years) who had laboratory testing through Quest Diagnostics.

The researchers found that 215,398 patients met the definition of newly diagnosed diabetes within the first six months of 2013 (control period), compared with 218,890 patients in 2014 (study period), representing a 1.6 percent increase. In the control period, the investigators identified 26,237 Medicaid-enrolled patients with new diabetes, compared with 29,673 in the study period, representing a 13 percent increase. During this period there was a 23 percent increase in the number of Medicaid-enrolled patients with newly identified diabetes in the 26 states and the District of Columbia that expanded Medicaid, compared with a 0.4 percent increase in the 24 states that did not expand Medicaid. The differences were similar for younger and older adults and for men and women.

"This study suggests that in the states that expanded Medicaid under the ACA, an increased number of Medicaid patients with diabetes are being diagnosed and treated earlier," the authors write. "This could be anticipated to lead to better long-term outcomes."

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »